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Abstract
Background: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality. CAP can trigger acute
cardiac events. We sought to determine the incidence of major cardiac complications in CAP patients to characterize the
magnitude of this problem.
Methods and Findings: Two investigators searched MEDLINE, Scopus, and EMBASE for observational studies of
immunocompetent adults with clinical and radiological evidence of CAP that reported any of the following: overall cardiac
complications, incident heart failure, acute coronary syndromes (ACS), or incident cardiac arrhythmias occurring within 30
days of CAP diagnosis. At a minimum, studies had to establish enrolment procedures and inclusion and exclusion criteria,
enrol their patients sequentially, and report the incidence of cardiac complications as a function of their entire cohorts.
Studies with focus on nosocomial or health care–associated pneumonia were not included. Review of 2,176 citations yielded
25 articles that met eligibility and minimum quality criteria. Seventeen articles (68%) reported cohorts of CAP inpatients. In
this group, the pooled incidence rates for overall cardiac complications (six cohorts, 2,119 patients), incident heart failure
(eights cohorts, 4,215 patients), acute coronary syndromes (six cohorts, 2,657 patients), and incident cardiac arrhythmias (six
cohorts, 2,596 patients), were 17.7% (confidence interval [CI] 13.9–22.2), 14.1% (9.3–20.6), 5.3% (3.2–8.6), and 4.7% (2.4–8.9),
respectively. One article reported cardiac complications in CAP outpatients, four in low-risk (not severely ill) inpatients, and
three in high-risk inpatients. The incidences for all outcomes except overall cardiac complications were lower in the two
former groups and higher in the latter. One additional study reported on CAP outpatients and low-risk inpatients without
discriminating between these groups. Twelve studies (48%) asserted the evaluation of cardiac complications in their
methods but only six (24%) provided a definition for them. Only three studies, all examining ACS, carried out risk factor
analysis for these events. No study analyzed the association between cardiac complications and other medical
complications or their impact on other CAP outcomes.
Conclusions: Major cardiac complications occur in a substantial proportion of patients with CAP. Physicians and patients
need to appreciate the significance of this association for timely recognition and management of these events. Strategies
aimed at preventing pneumonia (i.e., influenza and pneumococcal vaccination) in high-risk populations need to be
optimized. Further research is needed to understand the mechanisms underlying this association, measure the impact of
cardiac complications on other CAP outcomes, identify those patients with CAP at high risk of developing cardiac
complications, and design strategies to prevent their occurrence in this population.
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Community-acquired pneumonia (CAP) is a common and
deadly condition. In the United States alone, it is estimated that
each year CAP affects 5–6 million people, results in about 1.1
million hospital admissions, and causes the death of over 60,000
Americans, representing the most frequent cause of infectious
disease–related mortality and, along with influenza, the overall
eighth leading cause of death in this country [1,2].
CAPoccurs morefrequently inthemiddle aged and the elderly,a
population that is also at the highest risk for cardiac diseases [3,4].
Not surprisingly, more than half of elderly patients who present to
the hospital with CAP in the United States have preexisting chronic
cardiac conditions, and as the population continues to age, this
association will become more important [3,5].
Acute infections, including CAP, can affect the cardiovascular
system in various ways and have been recognized as precipitants of
acute cardiac events [6–8]. Although the possibility of major
cardiac complications occurring in a considerable proportion of
CAP patients is very plausible, systematic data on the magnitude
of this problem are remarkably scant [9]. Given the burden of
CAP in North America and other western societies [1,2], a careful
characterization of the risk of cardiac complications in patients
with this infection can have important implications for health
policy-making and direct patient care. This systematic review
examines the literature published on cardiac complications in
patients with CAP in an attempt to characterize the nature and
significance of this association, and to identify areas in this field
that require further investigation.
Methods
The PRISMA checklist is provided in Text S1.
Search Strategy
Our systematic search strategy was developed to capture all
articles of prognosis of CAP in which cardiac complications had
been reported and is presented in Text S2. We included articles
reporting in English, French, or Spanish languages. We searched
the following databases: MEDLINE (from 1950 to June 13, 2010),
Scopus (from 1960 to June 13, 2010), and EMBASE (from 1980 to
June 13, 2010). Reference lists of selected papers were also
screened for additional articles of interest.
Outcomes
Our outcomes consisted of the incidence of cardiac complica-
tions as a combined endpoint, incident (new or worsening) heart
failure, acute coronary syndromes (ACS; acute myocardial
infarction or unstable angina), and incident cardiac arrhythmias
within 30 d of CAP diagnosis.
Eligibility Criteria
To ensurethat theliteraturereviewed dealt with CAPratherthan
other conditions, we included only studies in which the definition of
CAP was supported by radiographic evidence of acute airspace
disease (new or progressing infiltrate within 48 h of presentation),
and clinical signs or symptoms of pulmonary infection. Only
observational studies reporting the occurrence of any of the cardiac
complications of interest in their results or stating the evaluation of
these outcomes in their methods were considered. At a minimum,
studies had to establish enrolment procedures and inclusion and
exclusion criteria in their methodological section, enrol their
patients sequentially, and report the incidence of cardiac compli-
cations as a function of their entire cohorts.
We excluded studies with focus on nosocomial or health care–
associated pneumonia, case series (defined as studies with #25
participants), articles without original data, antibiotic efficacy trials
(because they are usually restricted to highly selected patients), and
articles dealing primarily with pediatric patients or patients
infected with the human immunodeficiency virus. We also
excluded studies in which the inception time of their cohorts was
beyond 48 h from the diagnosis of pneumonia.
Selection of Studies
All titles and abstracts of the citations identified by our literature
search were independently screened by two investigators (VFC-M
and KNS). Relevant articles were reviewed in their entirety. Each
investigator made a recommendation for inclusion or exclusion of
single articles and if discordant, a third investigator solved the
discrepancy (GR). When two or more articles had overlap of their
populations and reported on the same cardiac outcomes, only the
most inclusive article was considered.
Data Extraction, Synthesis, and Analyses
We systematically collected data on the incidence of the cardiac
complications of interest, the characteristics of the populations
studied, and several aspects of the study setting and methodolog-
ical design (Table S1). We contacted (by e-mail) the corresponding
authors of those papers that offered no details of the methodology
followed for the ascertainment of the cardiac complications of
interest, and asked them to provide us with copies of the study
protocols (or similar) in which this information would be available.
Given the aim of our analyses, we focused on how rigorously the
evaluation of medical and/or cardiac complications was estab-
lished in the methodological considerations of these studies as an
indicator of their risk of bias in the ascertainment and reporting of
these outcomes and their quality relevant to our work. Publication
bias was assessed by preparing a funnel plot for the outcome of
overall cardiac complications.
Pooled incidence rates of cardiac complications were calculated
separately for studies dealing with outpatients, inpatients as a whole,
low-risk inpatients (e.g., inpatients with no indication for hospital
admission, low-risk pneumonia severity index categories, not
requiring admission to intensive care units, etc.), and high-risk
inpatients (i.e., patients admitted to intensive care units). We took this
approach to prevent heterogeneity in our estimates since these
categories represent distinct populations of CAP patients. We
performed prespecified subgroup analyses for studies of CAP
inpatients by characteristics of their study setting and design, quality
indicators of potential bias (see above), and attributes of their
populations. Because of the limited number of studies available, these
analysesarepresentedinadescriptiveformatonly.Pooledeventrates
and their confidence intervals (CIs) were estimated using a random
effects model weighted by the inverse variance. When only one study
was available, the Agresti-Coull method was used. All analyses were
conducted in comprehensive meta-analysis version 2.2.
Results
Our search strategy yielded 2,176 articles for review. A flow
summary of the selection process is provided in Figure 1. Table 1
presents a summarized description of the 25 ultimately selected
articles [10–34]. Two studies had overlapping study populations
[30,34], but since the smaller study reported on each of the four
cardiac complications of interest [30], while the larger one reported
only data on ACS [34], we kept both but considered only the latter
for analysesrelated to ACS. One articlereported on outpatients and
inpatients as separate groups [19], and for purposes of comparative
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Table S1 provides the most detailed information on the setting,
methodology, population, and findings of the included studies.
Assessment of Quality and Risk of Bias
The evaluation of medical and cardiac complications was
documented in the methodological considerations of 68% (17
cohorts, n=12,068) and 48% (12 cohorts, n=9,344) of the 25
studies, respectively; whereas definitions of the cardiac complica-
tions of interest were available for 24% (six cohorts, n=4,125) of
them (Table S1). Table 2 provides the stratification of the articles
by these quality elements for each of the cardiac complications of
interest. The definitions used for the ascertainment of cardiac
complications in the studies for which this information was
Figure 1. PRISMA flow diagram: selection process.
doi:10.1371/journal.pmed.1001048.g001
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studies, a visual inspection of our funnel plot for overall cardiac
complications did not allow for a meaningful assessment of
publication bias (Figure S1).
Overall Cardiac Complications
Six studies focused on CAP inpatients [13,22,23,29–31], one on
low-risk inpatients [28], and one on high-risk inpatients [17]; with
pooled incidence rates of 17.7% (CI 13.9–22.2) 5.9% (5.0–6.9),
and 2.3% (1.0–4.9) for each of these groups, respectively (Figure 2).
Incident Heart Failure
One study reported on outpatients [19], eight on inpatients
[11,12,18,19,21,30–32], three on low-risk inpatients [24,25,27]
and one on high-risk inpatients [26]. The pooled incidence rates
for each of these groups were 1.4% (0.8–2.5), 14.1% (9.3–20.6),
3.3% (1.0–10.5), and 23.9% (16.9–32.6), respectively (Figure 2).
Acute Coronary Syndromes
Five studies reported only on myocardial infarction [15,19,20,
31,33], one on unstable angina [27], and two on ACS in general
[32,34]. One study reported on outpatients and low-risk inpatients
without making distinction between them and was not accounted
for in the calculations of pooled rates [15]. One study focused on
outpatients [19], six on inpatients [19,20,31–34], and one on low-
risk inpatients [27], with pooled incidence rates of 0.1% (0.0–0.7),
5.3% (3.2–8.6), and 0.3% (0.01–1.3), respectively (Figure 2).
Incident Cardiac Arrhythmias
Five studies reported solely on atrial fibrillation
[10,14,15,31,32], one study on all atrial arrhythmias [19], two
on cardiac arrhythmias in general [16,26], and one on atrial
fibrillation (88% of the cases) and ventricular arrhythmias
(excluding terminal arrhythmias) [30]. One study reporting on
outpatients and low-risk inpatients without making distinction
between them was not included in the calculations of pooled rates
[15]. One study evaluated outpatients [19], six studied inpatients
[10,14,19,30–32], and two focused on high-risk inpatients [16,26];
giving pooled incidence rates of 0.9% (0.4–1.8), 4.7% (2.4–8.9),
and 18.5% (11.8–27.8), respectively (Figure 2).
Subgroup Analyses
Tables 3 and 4 describe the results of prespecified subgroup
analyses of studies on CAP inpatients by characteristics of their
setting, methodology, and population. Incident cardiac arrhythmias
and incident heart failure were more common in papers published
before 2000 and those coming from Europe. Overall cardiac
complications and ACS, on the other hand, were more frequent in
studies published between 2000 and 2005, and after 2005,
respectively, and in papers coming from North America. All cardiac
complications but ACS were more common in studies of
prospective multicenter design. Additionally, all cardiac complica-
tions tended to occur more frequently in studies in which the
evaluation of these events was stated in their methodological
considerations or a definition for their ascertainment was available.
Table 2. Studies of cardiac complications in patients with CAP: Methodological considerations for the ascertainment of medical
and cardiac complications.
Outcome Total References (n) Methods Section Established the Following:
Evaluation of Medical
Complications
References (n)
Evaluation of Cardiac
Complications
References (n)
Definition for Cardiac
Complications
References (n)
Overall cardiac complications
Outpatients — — — —
Inpatients [13,22,23,29–31] (2,119) [13,22,23,29–31] (2,119) [22,29–31] (1,751) [22,30,31] (1,169)
Low-risk inpatients [28] (2,471) [28] (2,471) [28] (2,471) —
High-risk inpatients [17] (299) [17] (299) — —
Incident heart failure
Outpatients [19] (907) [19] (907) [19] (907) [19] (907)
Inpatients [11,12,18,19,21,30–32] (4,215) [12,19,21,30,31] (3,054) [19,30,31] (1,904) [19,30,31] (1,904)
Low-risk inpatients [24,25,27] (2,469) [24,25] (1,883) [24,25] (1,883) —
High-risk inpatients [26] (113) [26] (113) [26] (113) —
ACS
Outpatients [19] (907) [19] (907) [19] (907) [19] (907)
Inpatients [19,20,31–33,24] (2,657) [19,31,33,34] (2,440) [19,31,33,34] (2,440) [19,31,33,34] (2,440)
Low-risk inpatients [27] (586) — — —
High-risk inpatients — — — —
Incident cardiac arrhythmias
Outpatients [19] (907) [19] (907) [19] (907) [19] (907)
Inpatients [10,14,19,30–32] (2,596) [19,30,31] (1,904) [19,30,31] (1,904) [19,30,31] (1,904)
Low-risk inpatients — — — —
High-risk inpatients [16,26] (173) [26] (113) [26] (113) —
One study reporting the incidence of ACS and incident cardiac arrhythmias on outpatients and low-risk inpatients without making distinction between them was not
included in this table [15].
doi:10.1371/journal.pmed.1001048.t002
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tended to be more common in studies with older populations and
higher rates of preexisting coronary artery disease, but not in those
with higher prevalence of preexisting congestive heart failure.
Studies of predominantly female populations had higher incidenc-
es of incident heart failure, whereas the opposite was observed for
overall cardiac complications. Rates of all cardiac complications
but incident heart failure were lower in studies of patients with
higher prevalence of diabetes mellitus. While overall cardiac
complications, incident heart failure and incident cardiac
arrhythmias were more common in studies with higher prevalence
of chronic obstructive pulmonary disease, the opposite was
observed for ACS. Finally, ACS occurred more commonly in
studies of patients with higher rates of smoking.
Risk Factors and Impact of Cardiac Complications on CAP
Outcomes
Only three studies [31,33,34], all dealing with CAP and ACS,
attempted to analyze risk factors for the occurrence of cardiac
complications. Possible risk factors identified included older age,
preexisting congestive heart failure [34], severity of pneumonia
[33], and the use of insulin by glucose sliding scales in hospitalized
patients [31]. No study analyzed the association of cardiac
complications with the development of other medical complica-
tions (i.e., acute renal failure, respiratory failure, shock, etc.), or the
impact of these events on other CAP outcomes (i.e., mortality).
Discussion
Our main finding is that major cardiac complications occur in a
significant proportion of patients with CAP, especially in those
requiring hospitalization for this infection. The pooled incidence
rates of overall cardiac complications, incident heart failure, ACS,
and incident arrhythmias in hospitalized patients with CAP were
17.7%, 14.1%, 5.3%, and 4.7%, respectively. Given the burden of
CAP in North America and other western societies [1,2], these
pooled findings have important implications. Firstly, clinicians
need to realize the significance of this association for appropriate
clinical alertness and to better inform CAP patients about the risk
of cardiac complications once the diagnosis of pneumonia is made.
Secondly, physicians and health officials need to increase efforts to
optimize the rates of influenza and pneumococcal vaccination
among the elderly and those with chronic cardiac conditions to
reduce the incidence of CAP in these high-risk populations.
Thirdly, attention needs to be directed to the potential impact of
cardiac complications in the mortality and cost associated with
CAP. Finally, the research community needs to urgently direct
more efforts to the study of this area.
Figure 2. Pooled rates of the incidence of cardiac complications in patients with CAP. One study reporting the incidence of ACS and
incident cardiac arrhythmias on outpatients and low-risk inpatients without making distinction between them was not included in the calculations of
pooled rates [15].
aFor definitions refer to Table 1.
bLow-risk inpatients included studies of inpatients with no indication for hospital admission,
pneumonia severity index (PSI) risk-classes I–II, not initially admitted to intensive care units or who survived the first 48 h of hospitalization. High-risk
inpatients included patients admitted to intensive care units.
cWhen only one study was available, the reported rate represents the study event rate.
doi:10.1371/journal.pmed.1001048.g002
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only previous systematic review on this topic reported four CAP
cohorts (232 patients total) with a pooled incidence of heart failure
of 8.6%. Our study not only confirms that incident heart failure is
common in the course of CAP but suggests that its occurrence in
patients hospitalized with this infection may be much higher than
previously realized, and that ACS and cardiac arrhythmias are
also remarkably frequent in this population.
Incident heart failure can be precipitated by CAP by several
mechanisms [7,30]. Acute inflammation can not only depress
myocardial function, as it is well described in septic states [35,36],
but it can also increase large artery stiffness and the pulse wave
reflections from peripheral middle-sized and small arteries that
returntotheheartinlate systole,increasingleftventricularafterload
and raising oxygen consumption [37]. Hypoxemia associated with
CAP can raise pulmonary arterial pressure and right ventricular
afterload while impairing myocardial oxygen delivery [7]. Tachy-
cardia, common in acute infections, increases myocardial oxygen
needs but shortens the diastolic period in which coronary perfusion
occurs [38–40]. The net result of these effects is a shift in the
metabolic supply/demand ratio of the myocardium and further
impairment of its function. These changes are presumed to be of
greater significance in patients with preexisting cardiac disease. In
addition, incident heart failure in CAP can result from myocardial
inflammation (myocarditis), a complication well described in
patients with pneumonia mainly of viral origin, and that could
have been underrepresented in previous investigations because of a
lack of adequate noninvasive techniques for its identification (i.e.,
cardiac magnetic resonance imaging) [41]. Finally, we realize that
acuterenal impairment,commoninhospitalized CAPpatients[19],
can also play a role in this setting [42].
Acute infections, including CAP, can also trigger the occurrence
of ACS, and clinical studies have shown a significant temporal
increase in the risk of ACS soon after the development of
respiratory infections [34,43,44]. Surges of biomechanical stress,
as a result of increased sympathetic activity and other hemody-
namic changes (i.e. alterations of the circulatory volume and the
systemic and coronary vascular tone), can prompt plaque rupture
Table 3. Studies of cardiac complications in inpatients with CAP: Subgroup analysis by study setting and design.
Subgroups Overall Cardiac Complications Incident Heart Failure ACS
Incident Cardiac
Arrhythmias
n
Studies
Incidence
(95% CI)
n
Studies
Incidence
(95% CI)
n
Studies Incidence
n
Studies
Incidence
(95% CI)
Year:
Before 2000 1 13.0 (9.5–17.5) 4 18.1 (10.8–28.7) 1 3.1 (2.3–4.2) 3 5.1 (1.5–15.7)
2000–2005 3 19.0 (13.3–26.3) 1 7.2 (6.0–8.6) 1 4.0 (1.2–10.2) — —
2006+ 2 18.0 (15.1–21.4) 3 12.9 (10.5–15.6) 4 7.1 (4.5–10.8) 3 4.1 (2.5–6.5)
Region:
North America 4 21.0 (18.2–24.2) 5 13.9 (9.7–19.5) 5 5.9 (3.6–9.5) 3 5.6 (2.6–11.8)
Latin America — — — — — — — —
Europe 2 9.3 (4.0–20.2) 3 15.1 (4.7–39.0) 1 0.9 (0.0–5.2) 2 7.1 (2.8–17.10
A s i a — — —— —— ——
Africa — — — — — — 1 1.0 (0.4–2.4)
Oceania — — — — — — — —
Design:
Prospective single—center 2 9.3 (4.0–20.2) 5 13.0 (6.9–23.0) 2 2.3 (0.5–9.5) 3 3.7 (0.9–14.2)
Prospective multicenter 2 23.0 (20.7–25.5) 1 20.8 (18.7–23.0) 1 3.1 (2.3–4.2) 1 9.5 (8.1–11.2)
Retrospective 2 18.0 (15.1–21.4) 2 13.1 (10.5–16.1) 3 7.8 (5.6–10.8) 2 4.0 (1.9–8,2)
Evaluation of medical
complications stated in
Methods section:
No — — 3 16.7 (5.9–39.0) 2 2.3 (0.5–9.5) 3 3.7 (0.9–14.2)
Yes 6 17.7 (13.9–22.2) 5 12.6 (7.8–19.8) 4 6.2 (3.6–10.5) 3 5.6 (2.6–11.8)
Evaluation of cardiac
complications stated in
Methods section:
No 2 9.3 (4.0–20.2) 5 13.0 (6.9–23.0) 2 2.3 (0.5–9.5) 3 3.7 (0.9–14.2)
Yes 4 21.0 (18.2–24.2) 3 15.9 (10.8–22.8) 4 6.2 (3.6–10.5) 3 5.6 (2.6–11.8)
Definition of cardiac
complications provided in
Methods section:
No 3 13.5 (6.7–25.3) 5 13.0 (6.9–23.0) 2 2.3 (0.5–9.5) 3 3.7 (0.9–14.2)
Yes 2 20.0 (17.0–23.2) 3 15.9 (10.8–22.8) 4 6.2 (3.6–10.5) 3 5.6 (2.6–11.8)
One study reporting the incidence of ACS and incident cardiac arrhythmias on outpatients and low-risk inpatients without making distinction between them was not
included in this table [15].
doi:10.1371/journal.pmed.1001048.t003
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increasing intraplaque inflammatory activity [7]. In this setting,
thrombus formation over a disrupted coronary plaque—a key step
in the development of ACS—would be favoured by infection-
induced prothrombotic changes in the blood and endothelium [7].
In addition, preexisting coronary artery disease that doesn’t
produce myocardial ischemia under baseline conditions can result
in significant ischemia in the face of increased metabolic demands
associated with CAP (i.e., demand ischemia; see above).
Most of the cardiac arrhythmias reported in the reviewed
studies represented atrial tachyarrhythmias, particularly atrial
fibrillation. Abnormalities in the cardiac conduction system in the
Table 4. Studies of cardiac complications in inpatients with CAP: subgroup analysis by baseline characteristics of the population.
Subgroups Overall Cardiac Complications Incident Heart Failure ACS
Incident Cardiac
Arrhythmias
n Studies
Incidence
(95% CI) n Studies
Incidence
(95% CI) n Studies
Incidence
(95% CI) n Studies
Incidence
(95% CI)
Age
,50 — — — — — — 1 1.0 (0.4–2.4)
50–65 — — 3 13.9 (7.8–23.5) 2 3.2 (2.4–4.2) 1 9.5 (8.1–11.2)
.65 5 17.2 (13.0–22.4) 4 14.3 (6.9–27.4) 4 7.1 (4.5–10.8) 3 5.1 (2.1–11.7)
Not reported 1 19.4 (14.1–26.0) 1 14.7 (10.1–20.9) — — 1 5.9 (3.1–10.6)
Gender:
,50% Male 4 16.7 (11.6–23.5) 2 19.1 (3.7–59.0) — — — —
.50%+ Male 2 18.0 (15.1–21.4) 6 12.5 (8.1–18.8) 6 5.3 (3.2–8.6) 6 4.7 (2.4–8.9)
Preexisting cardiac/
cardiovascular disease:
,2 5 % —— —— —— ——
25–50% — — — — — — — —
50%+ —— —— —— ——
Not reported 6 17.7 (13.9–22.2) 8 14.1 (9.3–20.6) 6 5.3 (3.2–8.6) 6 4.7 (2.4–8.9)
Coronary artery disease:
,25% — — 1 12.0 (7.1–19.2) 1 0.9 (0.0–5.2) 1 4.3 (1.6–9.9)
25–50% 2 23.0 (20.7–25.5) 3 13.9 (7.8–23.5) 3 5.8 (2.8–11.3) 1 9.5 (8.1–11.2)
50%+ —— —— —— ——
Not reported 4 14.5 (10.4–19.8) 4 15.0 (7.5–27.9) 2 6.5 (3.5–11.7) 4 3.8 (1.5–9.2)
Congestive heart failure:
,25% 4 18.8 (14.3–24.3) 2 16.3 (9.5–26.5) 3 6.4 (3.0–13.3) 2 5.4 (1.6–16.8)
25–50% — — 1 12.0 (7.1–19.2) 3 4.1 (1.9–8.5) 1 4.3 (1.6–9.9)
50%+ —— —— —— ——
Not reported 2 15.9 (10.6–23.1) 5 13.5 (7.4–23.5) — — 3 4.2 (1.1–14.1)
Diabetes mellitus:
,25% 3 21.3 (17.9–25.1) 5 11.6 (6.8–19.0) 3 6.4 (3.0–13.3) 2 5.4 (1.6–16.8)
25–50% 1 5.5 (2.1–12.5) 1 12.0 (7.1–19.2) 2 2.9 (0.5–16.0) 1 4.3 (1.6–9.9)
50%+ —— —— —— ——
Not reported 2 15.6 (10.6–23.1) 2 23.5 (9.0–48.8) 1 4.0 (1.2–10.2) 3 4.2 (1.1–14.1)
Chronic obstructive
pulmonary disease:
,25% 4 15.2 (10.0–22.4) 3 9.1 (5.8–14.2) 1 7.9 (5.6–11.1) 1 2.8 (1.5–5.0)
25–50% 1 22.0 (18.9–25.5) 2 15.6 (8.4–27.2) 3 5.8 (2.8–11.3) 1 9.5 (8.1–11.2)
50%+ — — 1 12.0 (7.1–19.2) 2 2.3 (0.5–9.5) 1 4.3 (1.6–9.9)
Not reported 1 19.4 (14.1–26,0) 2 23.5 (9.0–48.8) — — 3 4.2 (1.1–14.1)
Smoking:
,25% 1 24.1 (20.8–27.7) — — — — — —
25–50% — — 2 11.1 (8.9–13.9) 1 5.8 (4.0–8.2) 1 11.0 (5.4–20.4)
50%+ — — — — 2 7.2 (2.7–17.7) — —
Not reported 5 16.2 (12.2–21.1) 6 15.4 (9.3–24.3) 3 3.9 (1.6–9.2) 5 3.9 (1.8–8.4)
One study reporting the incidence of ACS and incident cardiac arrhythmias on outpatients and low-risk inpatients without making distinction between them was not
included in this table [15].
doi:10.1371/journal.pmed.1001048.t004
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20th century and consistently confirmed thereafter [45,46]. More
recently, a study of more than 800,000 patients admitted to the
hospital with atrial fibrillation as a secondary condition found that
in patients 65 y of age or older, the second leading primary
diagnosis was pneumonia (7%), after only congestive heart failure
(13%), and before acute myocardial infarction (6%) [8].
While incident heart failure, ACS, and cardiac arrhythmias
constitute distinct clinical entities, they share many pathophysio-
logical bases and risk factors, and the occurrence of one of them can
as well trigger the development of the others. While only one study
in our review clearly documented the frequent concomitant
occurrence of more than one cardiac complication in CAP patients
[30], we think that this scenario is likely to be rather common.
Our study highlights several shortcomings of the medical literature
on this area, which might influence our interpretations. Only a small
proportion of studies primarily focused on cardiac outcomes and very
few provided a definition for them, raising concerns for potential bias
in the ascertainment and/or reporting of these events in those studies
that did not. This is relevant especially for incident heart failure and
ACS since their manifestations can overlap with those of CAP and
other associated conditions (i.e., lung injury). Nevertheless, the few
studies that provided clear definitions for the cardiac complications of
interest consistently reported substantial incidences of these out-
comes, providing reassurance for the validity of our findings. Only
three studies of CAP and ACS looked at possible risk factors for the
occurrence of these events but their analyses were largely
underpowered and limited [31,33,34]. While it seems intuitive to
think that the presence of preexisting cardiac conditions should have
an important effect on the risk of cardiac complications in patients
with CAP, further research will be needed to delineate their
significance in this setting. As well, the association of cardiac
complications with the development of other medical complications
(i.e., acute renal failure, respiratory failure, shock, etc.), or the impact
of these events in other CAP outcomes (i.e., mortality) is yet to be
established. Finally, little is known about the timing of these
complications, and only one study suggested that ACS in CAP
patients tend to occur within few days after hospital admission [34].
Our work has limitations beyond the methodological shortcom-
ings of the individual analyzed studies. We cannot rule out potential
publication bias against studies that found no significant occurrenc-
es of cardiac complications. Additionally, we can only assume that
the diagnostic evaluations in individual studies were performed in a
uniform manner and the ascertainment of cardiac events was
correct. The small number of studies dealing with CAP populations
other than inpatients as a whole prevents us from drawing firm
conclusions on the incidence of cardiac complications in these
groups; and the finding of a counter-intuitively lower incidence of
overall cardiac complications in high-risk CAP inpatients could be
explainedbythisfactor.Theimplieddifferences inthe management
of inpatients and outpatients may have led to the under-reporting of
cardiac events in studies dealing with the latter group. Although
studies of cardiac complications in CAP inpatients were the most
common in our review, their number was still underpowered for
performing adequate analyses (i.e., meta-regression) of factors that
could account for the heterogeneity in their findings, and any
appreciable difference observed in our subgroup analyses should be
viewed in this context. Our review was limited to cardiac
complications occurring within 30 d from presentation with CAP
because it is assumed that the influence of the infection on patients’
comorbid conditions is maximal during this time [47]; however, it is
plausible that this influence can go beyond this period as it has been
suggested by recent studies [44,48]. Likewise, many of the
mechanisms implicated in the development of cardiac complica-
tions in patients with CAP could account for similar occurrences in
other infectious and noninfectious acute inflammatory states [7]. In
fact, evidence suggests that acute infections of the urinary and
gastrointestinal tract are also associated with increased risk of ACS
in the short term [7,44,49]. However, exploring the magnitude of
these associations was beyond the scope of our review.
Our findings highlight the urgent need for prospective, well-
designed, and adequately powered studies of cardiac complications
in patients with CAP. Investigations should focus on identifying risk
factors for the occurrence of cardiac complications in this population
and developing strategies to identify those CAP patients at high risk
for developing these events. These strategies may include clinical
scoring systems, biomarker-based approaches, noninvasive cardiac
imaging, or a combination of these. Studies are also needed to
characterize the impact of cardiac complications on the mortality
and resource utilization associated with CAP. Careful mechanistic
studies of the pathophysiology of cardiac complications in the course
ofCAP and theroleofpreexisting heart disease intheirdevelopment
should serve for the appropriate design of interventions aimed at
preventing their occurrence in high-risk groups. As an example,
discriminating between acute plaque rupture versus demand
ischemia as the factor driving the occurrence of ACS in this
population will have important and obvious therapeutic implica-
tions.Suchinterventionswillneed tobetested inrandomized clinical
trials. The ultimate goal will be to improve the outcomes of patients
with CAP and to decrease the burden that this disease imposes on
our health care systems through recognition of risk, prevention, and
intervention on acute cardiac complications.
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Background. Community-acquired pneumonia (CAP), that
is, pneumonia infections contracted outside of hospital or
health care settings, is a common condition and can be fatal,
particularly to older people. For example, every year, an
estimated 5–6 million people contract this form of
pneumonia in the US, leading to 1.1 million people being
admitted to hospitals and causing 60,000 deaths—the most
frequent cause of infectious disease-related mortality. In the
US for example, more than half of older patients who present
to the hospital with CAP have preexisting chronic cardiac
conditions—an important fact given that acute infections,
such as CAP, can affect the cardiovascular system in various
ways and precipitate acute cardiac events, such as heart
failure, heart attacks, and cardiac arrhythmias.
Why Was This Study Done? Although it is bio-medically
plausible that a considerable proportion of patients with CAP
have cardiac complications, systematic data on the scale of
this potential problem are lacking—a concerning omission
given the important implications for health policy-making
and direct patient care. Therefore, in this study, the
researchers conducted a systematic review to examine the
published literature on cardiac complications in patients with
CAP in order to characterize the nature and significance of
this association, and to identify areas that require further
research and investigation.
What Did the Researchers Do and Find? The researchers
searched MEDLINE, Scopus, and EMBASE for all relevant
articles published in English, French, or Spanish languages
until June 2010. The researchers used strict criteria to select
appropriate articles (such as radiographic evidence of CAP)
and only selected studies that had outcomes of the
incidence of cardiac complications, such as incident (new
or worsening) heart failure, acute coronary syndromes (acute
myocardial infarction or unstable angina), and incident
cardiac arrhythmias within 30 days of diagnosis of CAP.
Using these methods, the researchers identified 2,176 articles
for review and selected 25 eligible papers for their analysis.
Seventeen articles (68%) reported cohorts of CAP inpatients.
In this group, the pooled incidence rates of overall cardiac
complications (six cohorts, 2,119 patients), incident heart
failure (eight cohorts, 4,215 patients), acute coronary
syndromes (six cohorts, 2,657 patients), and incident cardiac
arrhythmias (six cohorts, 2,596 patients), were 17.7%, 14.1%,
5.3%, and 4.7% respectively. Only three studies, (all of acute
coronary syndromes) did risk factor analysis for these events.
Possible risk factors identified included older age, preexisting
congestive heart failure, severity of pneumonia, and the use
of insulin by glucose sliding scales in hospitalized patients.
No study analyzed the association between cardiac compli-
cations and other medical complications (such as acute renal
failure, respiratory failure, shock, etc.) or their impact on
other outcomes, such as death, in patients with CAP.
What Do These Findings Mean? Although limited to a
mostly descriptive analysis, these findings clearly show that
major cardiac complications occur in a significant proportion
of patients with CAP, especially in those admitted to
hospital. These findings have important clinical and public
health implications. Clinicians should be more aware of the
significance of the association between CAP and cardiac
complications to better inform, treat, and manage patients.
Physicians and health officials need to increase efforts to
optimize the rates of influenza and pneumococcal
vaccination among older people and those with chronic
cardiac conditions to reduce the incidence of CAP in these
high-risk populations. There needs to be more consideration
given to the potential impact of cardiac complications on
mortality and costs associated with CAP. Finally, these
findings highlight the need for prospective, well-designed,
and adequately powered studies of cardiac complications in
patients with CAP. More research attention should be given
to this important area in order to improve the outcomes for
patients with CAP and to decrease the consequent burden
on health care systems through recognition of risk,
prevention, and intervention on acute cardiac complications.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001048.
N Information can be found on Wikipedia on community-
acquired pneumonia (note that Wikipedia is a free online
encyclopedia that anyone can edit; available in several
languages)
N The US Centers for Disease Control provide patient
information on community-acquired pneumonia
N The American Heart Association provides information on
heart failure, acute coronary syndromes, and arrhythmias
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